ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients-Reference-Cited by-同舟云学术

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients

Published:2019-04-19 Issue:12 Volume:104 Page:e562-e565
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Sibon David,Nguyen Dinh-Phong,Schmitz Norbert,Suzuki Ritsuro,Feldman Andrew L.,Gressin Rémy,Lamant Laurence,Weisenburger Dennis D.,Rosenwald Andreas,Nakamura Shigeo,Ziepert Marita,Maurer Matthew J.,Bast Martin,Armitage James O.,Vose Julie M.,Tilly Hervé,Jais Jean-Philippe,Savage Kerry J.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study;The Lancet Haematology;2024-09

2. Etoposide addition and brentuximab vedotin consolidation in first-line treatment of CD30-positive peripheral T-cell lymphoma: can we improve BV–CHP?;The Lancet Haematology;2024-09

3. Next Questions in Peripheral T-Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-09

4. Non-Hodgkin's Anaplastic Large T-Cell Lymphoma: A Case Report;Cureus;2024-06-24

5. Case report: The utilization of crizotinib and brentuximab vedotin as a bridge to autologous stem cell transplantation and followed by CD30-directed CAR-T cell therapy in relapsed/refractory ALK+ ALCL;Frontiers in Immunology;2024-02-05